Q: How can I be expected to trust the safety of the COVID-19 vaccine when it was developed so rapidly? A: We hear this question
Read morePeople who had received a first dose of the Oxford-AstraZeneca COVID-19 vaccine and received an mRNA vaccine for their second dose had a lower risk
Read moreThough survival rates for children diagnosed with cancer are improving, not all children respond to current medical treatments. Cancers in children, adolescents and young adults
Read moreDespite smoking’s well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked. While scientists are still working
Read moreAs the COVID-19 pandemic unfolded in the UK, the virus and its related lockdown measures had unequal and varying impacts on people’s income, time use,
Read morePeople that are particularly sensitive to stress hormones also exhibit markers that suggest they are at greater risk of developing cardiovascular disease, according to research
Read moreInside our brains lives a myriad of cell types that support complex human thought—from our ability to make memories and decisions, to our capacity for
Read moreIn a study with mice reported today in the journal Science Translational Medicine, a Johns Hopkins Medicine research team has provided what may be the
Read moreMathematical constructions of the action of SARS-CoV-2 and its multiple spikes, which enable its success at infecting cells, can give vaccine developers and pharmaceutical companies
Read moreIt is generally accepted in the medical industry that adverse psychosocial factors are linked to cardiovascular disease (CVD). A new study used quantitative meta-analysis, a
Read more